From: Genome-wide association study of susceptibility loci for breast cancer in Sardinian population
Characteristic | Patients, n (%) |
---|---|
Pathological TNM classification | |
 pT1-2 | 830 (90.1) |
 pT3-4 | 91 (9.9) |
 pN0 | 533 (57.9) |
 pN1 | 388 (42.1) |
 M0 | 751 (81.5) |
 M1 | 43 (4.7) |
 Mx | 127 (13.8) |
Receptor status | |
 ER- | 234 (25.4) |
 ER+ | 687 (74.6) |
 PR- | 260 (28.2) |
 PR+ | 661 (71.8) |
 HER2- | 601 (65.3) |
 HER2+ | 174 (18.9) |
 Not tested | 146 (15.8) |
Molecular subtypea | |
 ER+/PR+/HER2- | 545 (70.3) |
 ER+/PR+/HER2+ | 142 (18.3) |
 ER-/PR-/HER2+ | 32 (4.1) |
 Triple negative (ER-/PR-/HER2-) | 56 (7.2) |